CVI Holdings’s Altimmune ALT Stock Holding History

CVI Holdings’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,600	Closed	-$140K	–	182
2020 Q3	$140K	Sell	10,600 -18,800	-64%	-$376K	0.06%	66
2020 Q2	$315K	Buy	+29,400	New	+$162K	0.12%	50
2018 Q4	–	Sell	-92,768	Closed	-$408K	–	41
2018 Q3	$408K	Buy	+92,768	New	+$1.01M	0.67%	20

Other funds holding ALT

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CVI Holdings's ALT Position: Q4 2020 in Review

CVI Holdings sold out of Altimmune (ALT) in Q4 2020, closing a stake of 10,600 shares — an estimated $140K sold.

CVI Holdings first reported a position in ALT in Q3 2018 and held it in 3 quarters. The position peaked at $408K in Q3 2018. 89 funds tracked by Wall St. Rank hold ALT as of Q4 2020.

CVI Holdings reported no remaining Altimmune position as of Q4 2020 after selling out during the quarter.
CVI Holdings sold 10,600 Altimmune shares in Q4 2020, an estimated $140K.
CVI Holdings first reported a position in Altimmune in Q3 2018 and held it in 3 quarters.
CVI Holdings's Altimmune position peaked at $408K in Q3 2018.
89 funds tracked by Wall St. Rank held Altimmune as of Q4 2020.

Based on CVI Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.